Home » Scottish Firm Targets South Korea for Cancer Patch
Scottish Firm Targets South Korea for Cancer Patch
Scottish company ProStrakan has landed a South Korean partner for its novel transdermal patch for chemotherapy-induced nausea, the firm’s first patch product with ambitions to steal a sizeable chunk of a €2bn market.
Outsourcing-Pharma.com
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May